PFIZER TO DELIVER 200 MILLION COVID-19 VACCINE DOSES TO EU IN SECOND QUARTER
The European Commission expects to receive about 200 million doses of the Pfizer/BioNTech Covid-19 vaccine in the second quarter, it said for the first time on Tuesday (March 16).
The European Union is aiming to vaccinate at least 255 million people, or 70 per cent of its adult population, by the end of the summer but has faced criticism for the slow roll-out of its inoculation drive.
Besides supply delays from some drugmakers and hiccups in vaccination plans, the suspension of inoculations using the AstraZeneca vaccine due to potential health issues is also affecting the bloc's campaign.
The EU had not previously said how many doses of the Pfizer/BioNTech vaccine, which is administered in two shots, it would receive in the April to June period under two confidential supply contracts with the drugmakers.
The expected Pfizer second-quarter deliveries will include 10 million doses originally due in the third and fourth quarters of this year, the commission said.
The announcement does not change the EU's overall forecast for vaccine supplies of 300 million doses in the second quarter from all the drugmakers the bloc has signed contracts with.